Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $725,445 - $1.14 Million
684,383 Added 931.88%
757,824 $879,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $70,866 - $100,674
56,243 Added 327.03%
73,441 $124,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $27,688 - $43,682
17,198 New
17,198 $31,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $96,758 - $176,584
80,632 New
80,632 $107,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.